4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene

C184H122N6 — CID 159405738

IUPAC4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene
SMILESCc1nc2ccc(-c3ccc(-c4c5ccccc5c(-c5ccccc5)c5ccccc45)cc3)cc2n1-c1ccccc1.c1ccc(-c2c3ccccc3c(-c3ccc(-c4cccc5ccccc45)cc3)c3ccccc23)cc1.c1ccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)cc1.c1ccc(-c2ccc(-c3nc(-c4cc5ccccc5c5ccccc45)cc(-c4cc5ccccc5c5ccccc45)n3)cc2)nc1.c1cncc(-c2ccc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4ccccc34)cc2)c1
InChIInChI=1S/C43H27N3.C40H28N2.C36H24.C35H23N.C30H20/c1-3-13-32-30(11-1)25-38(36-17-7-5-15-34(32)36)41-27-42(39-26-31-12-2-4-14-33(31)35-16-6-8-18-37(35)39)46-43(45-41)29-22-20-28(21-23-29)40-19-9-10-24-44-40;1-27-41-37-25-24-31(26-38(37)42(27)32-14-6-3-7-15-32)28-20-22-30(23-21-28)40-35-18-10-8-16-33(35)39(29-12-4-2-5-13-29)34-17-9-11-19-36(34)40;1-2-12-27(13-3-1)35-31-16-6-8-18-33(31)36(34-19-9-7-17-32(34)35)28-23-21-26(22-24-28)30-20-10-14-25-11-4-5-15-29(25)30;1-2-9-27-22-28(20-17-24(27)8-1)35-32-13-5-3-11-30(32)34(31-12-4-6-14-33(31)35)26-18-15-25(16-19-26)29-10-7-21-36-23-29;1-2-11-22(12-3-1)29-25-14-6-8-16-27(25)30(28-17-9-7-15-26(28)29)24-19-18-21-10-4-5-13-23(21)20-24/h1-27H;2-26H,1H3;1-24H;1-23H;1-20H
InChIKeyLNXSSFWXVQAFJM-UHFFFAOYSA-N
MW2417.04 g/mol
LogP49.96
Rot. Bonds16

About 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene

4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene (PubChem CID 159405738) has the molecular formula C184H122N6 and a molecular weight of 2417.04 g/mol. Its IUPAC name is 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene.

Molecular Properties

Compound Name4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene
PubChem CID159405738
Molecular FormulaC184H122N6
Molecular Weight2417.04 g/mol
Exact Mass2414.97
IUPAC Name4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene
SMILESCc1nc2ccc(-c3ccc(-c4c5ccccc5c(-c5ccccc5)c5ccccc45)cc3)cc2n1-c1ccccc1.c1ccc(-c2c3ccccc3c(-c3ccc(-c4cccc5ccccc45)cc3)c3ccccc23)cc1.c1ccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)cc1.c1ccc(-c2ccc(-c3nc(-c4cc5ccccc5c5ccccc45)cc(-c4cc5ccccc5c5ccccc45)n3)cc2)nc1.c1cncc(-c2ccc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4ccccc34)cc2)c1
InChIInChI=1S/C43H27N3.C40H28N2.C36H24.C35H23N.C30H20/c1-3-13-32-30(11-1)25-38(36-17-7-5-15-34(32)36)41-27-42(39-26-31-12-2-4-14-33(31)35-16-6-8-18-37(35)39)46-43(45-41)29-22-20-28(21-23-29)40-19-9-10-24-44-40;1-27-41-37-25-24-31(26-38(37)42(27)32-14-6-3-7-15-32)28-20-22-30(23-21-28)40-35-18-10-8-16-33(35)39(29-12-4-2-5-13-29)34-17-9-11-19-36(34)40;1-2-12-27(13-3-1)35-31-16-6-8-18-33(31)36(34-19-9-7-17-32(34)35)28-23-21-26(22-24-28)30-20-10-14-25-11-4-5-15-29(25)30;1-2-9-27-22-28(20-17-24(27)8-1)35-32-13-5-3-11-30(32)34(31-12-4-6-14-33(31)35)26-18-15-25(16-19-26)29-10-7-21-36-23-29;1-2-11-22(12-3-1)29-25-14-6-8-16-27(25)30(28-17-9-7-15-26(28)29)24-19-18-21-10-4-5-13-23(21)20-24/h1-27H;2-26H,1H3;1-24H;1-23H;1-20H
InChIKeyLNXSSFWXVQAFJM-UHFFFAOYSA-N
XLogP49.96
TPSA69.38 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds16
Heavy Atoms190
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5002417.04
LogP ≤ 549.96
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene?
The IUPAC name of 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene (CID 159405738) is 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene.
What is the SMILES notation for 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene?
The canonical SMILES for 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene is Cc1nc2ccc(-c3ccc(-c4c5ccccc5c(-c5ccccc5)c5ccccc45)cc3)cc2n1-c1ccccc1.c1ccc(-c2c3ccccc3c(-c3ccc(-c4cccc5ccccc45)cc3)c3ccccc23)cc1.c1ccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)cc1.c1ccc(-c2ccc(-c3nc(-c4cc5ccccc5c5ccccc45)cc(-c4cc5ccccc5c5ccccc45)n3)cc2)nc1.c1cncc(-c2ccc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4ccccc34)cc2)c1.
What is the InChIKey of 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene?
The InChIKey is LNXSSFWXVQAFJM-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H27N3.C40H28N2.C36H24.C35H23N.C30H20/c1-3-13-32-30(11-1)25-38(36-17-7-5-15-34(32)36)41-27-42(39-26-31-12-2-4-14-33(31)35-16-6-8-18-37(35)39)46-43(45-41)29-22-20-28(21-23-29)40-19-9-10-24-44-40;1-27-41-37-25-24-31(26-38(37)42(27)32-14-6-3-7-15-32)28-20-22-30(23-21-28)40-35-18-10-8-16-33(35)39(29-12-4-2-5-13-29)34-17-9-11-19-36(34)40;1-2-12-27(13-3-1)35-31-16-6-8-18-33(31)36(34-19-9-7-17-32(34)35)28-23-21-26(22-24-28)30-20-10-14-25-11-4-5-15-29(25)30;1-2-9-27-22-28(20-17-24(27)8-1)35-32-13-5-3-11-30(32)34(31-12-4-6-14-33(31)35)26-18-15-25(16-19-26)29-10-7-21-36-23-29;1-2-11-22(12-3-1)29-25-14-6-8-16-27(25)30(28-17-9-7-15-26(28)29)24-19-18-21-10-4-5-13-23(21)20-24/h1-27H;2-26H,1H3;1-24H;1-23H;1-20H.
What are the key properties of 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene?
4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene has a molecular weight of 2417.04 g/mol, XLogP of 49.96, 16 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4,6-di(phenanthren-9-yl)-2-(4-pyridin-2-ylphenyl)pyrimidine;2-methyl-1-phenyl-6-[4-(10-phenylanthracen-9-yl)phenyl]benzimidazole;3-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]pyridine;9-naphthalen-2-yl-10-phenylanthracene;9-(4-naphthalen-1-ylphenyl)-10-phenylanthracene is sourced from PubChem (CID 159405738), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).